- Filed
- May 17, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · May 12, 2021 | 90.54M sh |
| Shares Diluted | Q1 2021 · Mar 31, 2021 | 75.82M sh |
| Shares Diluted | Q1 2021 · Mar 31, 2020 | 34.35M sh |
| Capex | Q1 2021 · Mar 31, 2021 | $525K |
| Capex | Q1 2021 · Mar 31, 2020 | $930K |
| Operating Cash Flow | Q1 2021 · Mar 31, 2021 | −$7.89M |
| Operating Cash Flow restated | Q1 2021 · Mar 31, 2020 | −$3.95M |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $32.53M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $38.75M |
| Cash And Equivalents restated | Q1 2021 · Mar 31, 2020 | $5.88M |
| Cash And Equivalents restated | Q1 2021 · Dec 31, 2019 | $4.54M |
| Stockholders Equity | Q1 2021 · Mar 31, 2021 | $145.33M |
| Stockholders Equity | Q1 2021 · Dec 31, 2020 | $55.07M |
| Stockholders Equity restated | Q1 2021 · Mar 31, 2020 | −$108.55M |
| Stockholders Equity restated | Q1 2021 · Dec 31, 2019 | −$99.94M |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $18.42M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $15.94M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $126.68M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $29.87M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $50.36M |
| Current Assets | Q1 2021 · Dec 31, 2020 | $49.08M |
| Total Assets | Q1 2021 · Mar 31, 2021 | $272M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $84.94M |
| Eps Diluted | Q1 2021 · Mar 31, 2021 | −$0.17 |
| Eps Diluted | Q1 2021 · Mar 31, 2020 | −$0.25 |
| Eps Basic | Q1 2021 · Mar 31, 2021 | −$0.17 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | −$0.25 |
| Sga Expense | Q1 2021 · Mar 31, 2021 | $21.26M |
| Sga Expense | Q1 2021 · Mar 31, 2020 | $8.52M |
| Net Income | Q1 2021 · Mar 31, 2021 | $100K |
| Net Income | Q1 2021 · Mar 31, 2021 | −$12.6M |
| Net Income restated | Q1 2021 · Mar 31, 2020 | −$7.22M |
| Operating Income | Q1 2021 · Mar 31, 2021 | −$16.21M |
| Operating Income restated | Q1 2021 · Mar 31, 2020 | −$4.43M |
| Cost Of Revenue | Q1 2021 · Mar 31, 2021 | $9.77M |
| Cost Of Revenue | Q1 2021 · Mar 31, 2020 | $10.71M |
| Revenue | Q1 2021 · Mar 31, 2021 | $400K |
| Revenue | Q1 2021 · Mar 31, 2021 | $14.82M |
| Revenue | Q1 2021 · Mar 31, 2020 | $14.81M |